Senior Principal Scientist, Head of Biologics Modeling
Certara UK (Simcyp Division)
SHEFFIELD, England, United Kingdom
Armin Sepp is Senior Principal Scientist and Head of Biologics Modelling at Certara Ltd. His background is in bioorganic chemistry and a PhD in enzyme kinetics, complemented by postdoctoral training in protein engineering and in vitro antibody evolution at the MRC Laboratory of Molecular Biology in Cambridge. Pharmaceutical career began with human domain antibody engineering at the Domantis Ltd start-up in Cambridge, followed by GlaxoSmithKline, where he became Scientific Leader and GSK Fellow in the DMPK Modelling group. At GSK, he established a quantitative, mechanistic, full-body physiologically-based pharmacokinetic modelling platform for biologics. This supported drug discovery projects for mAbs, antibody fragments and other modalities across diverse therapy areas, ranging from immuno-inflammation to oncology and gene therapy. At Certara, the focus remains on cross-platform/cross-species PBPK modelling of protein therapeutics, but he is also keeping a keen eye on developments in machine learning and quantitative systems pharmacology.
Disclosure information not submitted.
Quantitative Mechanistic Pharmacology of Cell and Gene Therapies
Wednesday, May 13, 2026
10:30 AM - 11:00 AM PT